Recent Biotech Financings: Viamet, Intellikine, Xenoport, Zosano
This article was originally published in The Pink Sheet Daily
Executive Summary
At least for these four companies, there are no summer doldrums in investment activity; Viamet is a notable example of increased participation by big pharma venture groups in early-stage biotech financings.